Matches in SemOpenAlex for { <https://semopenalex.org/work/W1566226495> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W1566226495 endingPage "2400" @default.
- W1566226495 startingPage "2393" @default.
- W1566226495 abstract "To study potential sources of tumor-associated Ags in human ovarian cancer, we have established two ovarian tumor cell lines (OvS1 and OvA2) from two ovarian cancer patients, which express the cellular oncogene HER2/neu. Corresponding tumor infiltrating lymphocyte cultures have also been established and display an autologous tumor-specific pattern of cytotoxicity that is HLA-A2 restricted. To determine the potential relationship between HER2/neu expression and CTL-mediated cytolysis, we first established tumor cell clones from OvS1. These were categorized as high or low expressors of HER2/neu (cOvS1+ or cOvS1-, respectively), and cOvS1+ clones displayed a significantly higher sensitivity to CTL killing as compared with cOvS1- clones. To modulate the expression of HER2/neu, ovarian cancer cells were treated with IFN-gamma. After this exposure, HER2/neu expression was significantly decreased, whereas the expression of HLA Class I was significantly increased. Despite the increase in HLA Class I molecules on the cell surface, CTL-mediated cytolysis of both OvS1 and OvA2 was significantly decreased. IFN-gamma treated cOvS1+ clones displayed a similar decrease in sensitivity to CTL killing, whereas IFN-gamma treated cOvS1- clones displayed an increase or no change in sensitivity to CTL. To confirm this apparent association between HER2/neu expression and CTL recognition, melanoma tumor cell lines that were insensitive to ovarian tumor-specific CTL were transfected with the HER2/neu gene. An HLA-A2+ HER2/neu-transfected melanoma cell line was made sensitive to HLA-A2 restricted ovarian tumor-specific CTL but not to HLA-A2 unrestricted CTL, whereas an HLA-A2- HER2/neu-transfected melanoma remained insensitive to HLA-A2 restricted CTL. These results demonstrate that the sensitivity of ovarian epithelial tumor cells to CTL-mediated lysis is associated with the level of expression of HER2/neu, suggesting that this oncogene product may serve as a source of tumor-associated Ags or as an inducer of such peptides. This is the first time in a human tumor system that oncogene expression has been related to the induction of antigenicity. These results prompt us to approach new strategies for immunotherapy of cancer." @default.
- W1566226495 created "2016-06-24" @default.
- W1566226495 creator A5030864419 @default.
- W1566226495 creator A5032371242 @default.
- W1566226495 creator A5044161354 @default.
- W1566226495 creator A5062157417 @default.
- W1566226495 creator A5082092102 @default.
- W1566226495 date "1994-03-01" @default.
- W1566226495 modified "2023-10-17" @default.
- W1566226495 title "Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer." @default.
- W1566226495 doi "https://doi.org/10.4049/jimmunol.152.5.2393" @default.
- W1566226495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8133050" @default.
- W1566226495 hasPublicationYear "1994" @default.
- W1566226495 type Work @default.
- W1566226495 sameAs 1566226495 @default.
- W1566226495 citedByCount "58" @default.
- W1566226495 countsByYear W15662264952012 @default.
- W1566226495 crossrefType "journal-article" @default.
- W1566226495 hasAuthorship W1566226495A5030864419 @default.
- W1566226495 hasAuthorship W1566226495A5032371242 @default.
- W1566226495 hasAuthorship W1566226495A5044161354 @default.
- W1566226495 hasAuthorship W1566226495A5062157417 @default.
- W1566226495 hasAuthorship W1566226495A5082092102 @default.
- W1566226495 hasBestOaLocation W15662264951 @default.
- W1566226495 hasConcept C121608353 @default.
- W1566226495 hasConcept C147969180 @default.
- W1566226495 hasConcept C1491633281 @default.
- W1566226495 hasConcept C154317977 @default.
- W1566226495 hasConcept C167672396 @default.
- W1566226495 hasConcept C202751555 @default.
- W1566226495 hasConcept C203014093 @default.
- W1566226495 hasConcept C2776872082 @default.
- W1566226495 hasConcept C2777658100 @default.
- W1566226495 hasConcept C2780084626 @default.
- W1566226495 hasConcept C2780427987 @default.
- W1566226495 hasConcept C2781018059 @default.
- W1566226495 hasConcept C29537977 @default.
- W1566226495 hasConcept C502942594 @default.
- W1566226495 hasConcept C530470458 @default.
- W1566226495 hasConcept C54009773 @default.
- W1566226495 hasConcept C54355233 @default.
- W1566226495 hasConcept C55493867 @default.
- W1566226495 hasConcept C73588182 @default.
- W1566226495 hasConcept C81885089 @default.
- W1566226495 hasConcept C86803240 @default.
- W1566226495 hasConcept C8891405 @default.
- W1566226495 hasConceptScore W1566226495C121608353 @default.
- W1566226495 hasConceptScore W1566226495C147969180 @default.
- W1566226495 hasConceptScore W1566226495C1491633281 @default.
- W1566226495 hasConceptScore W1566226495C154317977 @default.
- W1566226495 hasConceptScore W1566226495C167672396 @default.
- W1566226495 hasConceptScore W1566226495C202751555 @default.
- W1566226495 hasConceptScore W1566226495C203014093 @default.
- W1566226495 hasConceptScore W1566226495C2776872082 @default.
- W1566226495 hasConceptScore W1566226495C2777658100 @default.
- W1566226495 hasConceptScore W1566226495C2780084626 @default.
- W1566226495 hasConceptScore W1566226495C2780427987 @default.
- W1566226495 hasConceptScore W1566226495C2781018059 @default.
- W1566226495 hasConceptScore W1566226495C29537977 @default.
- W1566226495 hasConceptScore W1566226495C502942594 @default.
- W1566226495 hasConceptScore W1566226495C530470458 @default.
- W1566226495 hasConceptScore W1566226495C54009773 @default.
- W1566226495 hasConceptScore W1566226495C54355233 @default.
- W1566226495 hasConceptScore W1566226495C55493867 @default.
- W1566226495 hasConceptScore W1566226495C73588182 @default.
- W1566226495 hasConceptScore W1566226495C81885089 @default.
- W1566226495 hasConceptScore W1566226495C86803240 @default.
- W1566226495 hasConceptScore W1566226495C8891405 @default.
- W1566226495 hasIssue "5" @default.
- W1566226495 hasLocation W15662264951 @default.
- W1566226495 hasLocation W15662264952 @default.
- W1566226495 hasOpenAccess W1566226495 @default.
- W1566226495 hasPrimaryLocation W15662264951 @default.
- W1566226495 hasRelatedWork W152541474 @default.
- W1566226495 hasRelatedWork W1976818007 @default.
- W1566226495 hasRelatedWork W1980416103 @default.
- W1566226495 hasRelatedWork W1991634 @default.
- W1566226495 hasRelatedWork W2023301100 @default.
- W1566226495 hasRelatedWork W2160379231 @default.
- W1566226495 hasRelatedWork W2389302246 @default.
- W1566226495 hasRelatedWork W2417644438 @default.
- W1566226495 hasRelatedWork W2107997786 @default.
- W1566226495 hasRelatedWork W2185215548 @default.
- W1566226495 hasVolume "152" @default.
- W1566226495 isParatext "false" @default.
- W1566226495 isRetracted "false" @default.
- W1566226495 magId "1566226495" @default.
- W1566226495 workType "article" @default.